Table 1.

Patient characteristics

Patient characteristics	n	%
Gender
Male	617	43
Female	829	57
Age (years)
<50	246	17
50–59	271	19
60–69	395	27
70–79	395	27
≥80	139	10
Diagnoses
Hematological neoplasms	620	43
Myeloproliferative disease	184	30
Non-Hodgkin's lymphoma	137	22
Chronic lymphocytic leukemia	106	17
Multiple myeloma	76	12
Myelodysplastic Syndrome	59	10
Hodgkin's disease	18	3
Hairy cell leukemia	15	2
Acute myeloid leukemia	14	2
Acute lymphocytic leukemia	8	1
Other lymphocytic leukemia	3	0.5
Solid tumors	598	41
Breast	236	39
Digestive organs	103	17
Respiratory and intrathoracic organs	65	11
Male genital organs	64	11
Female genital organs	33	6
Urinary tract	27	5
Skin	17	3
Cancer of unknown primary	13	2
Eye, brain, CNS	11	2
Mesothelialan soft tissue	11	2
Lip, oral cavity and pharynx	8	1
Thyroid and other endocrine glands	6	1
In situ neoplasms	2	0.3
Bone and articular cartilage	2	0.3
Benign hematological diseases	154	11
Anemia	53	34
Purpura and other hemorrhagic conditions	31	20
Other diseases of blood and blood-forming organs	30	19
Monoclonal gammopathy	19	12
Common variable immunodeficiency syndrome	14	9
Coagulation defect	6	4
Exclusion of disease	1	1
Other nonmalignant diseases	74	5
Autoimmune disease	47	64
Hemochromatosis	13	18
Infection	6	8
Other nonmalignant diseases	5	7
Benign neoplasms	2	3
Exclusion of disease	1	1
Treatment phases
Observation	270	19
Palliative chemotherapy	225	16
Oral chemotherapy only	217	15
Other therapy (mostly bisphosphonates or immunosuppressive therapy)	139	10
Follow-up	126	9
Patients within diagnostic workup	122	8
Best supportive care	88	6
Palliative antihormonal therapy	62	4
Adjuvant chemotherapy	60	4
Adjuvant antihormonal therapy	52	4
Advice/second opinion	50	3
First diagnosis	21	1
Diagnosis of relapse/metastases	14	1

CNS, central nervous system.